OPRM1 and cancer: Currently, exogenous opiates are the standard treatment for cancer-related pain; the primary mechanism of action is in the spinal cord and brain through binding to the widely expressed μ-opioid receptor (OPRM1), with minimal direct inhibition of the primary sensory nerves innervating the tissue5.